IREN Limited (NASDAQ: IREN) (“IREN”) today announced the pricing of its offering of $2.6 billion aggregate principal amount of 1.00% convertible senior notes due 2033 (the “notes”) in a private ...
IREN Limited (NASDAQ:IREN) shares fell 6% on Monday after the company announced plans to launch a $2 billion offering of ...
Today, May 11, 2026, investors are weighing fresh debt, an earnings miss, and a sprawling Nvidia-backed AI buildout.
Travere Therapeutics (TVTX) on Wednesday announced the pricing of its underwritten offering of $475M aggregate principal amount of 0.50% convertible senior notes due 2032. The sale of the notes is ...
IREN Limited (NASDAQ: IREN) ("IREN") today announced its intention to offer, subject to market and other conditions, $2 billion aggregate principal amount of ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today ...